Hologic Inc. ($HOLX) Stock Forecast: Down 2.9% Today

What is Hologic Inc.?

Hologic (HOLX) is a company specializing in medical diagnostic products, including imaging systems and surgical products. The overall market sentiment for HOLX today was bearish.

Why is Hologic Inc. going down?

HOLX stock is down 2.9% on Oct 13, 2025 19:55

• HOLX stock decreased by -1.25%, closing at $67.76.
• The bearish movement may stem from profit-taking by investors following a recent uptrend in the stock.
• Investor caution could be linked to competition in the medical diagnostic industry or overall market volatility affecting HOLX.
• Some investors could be reassessing their HOLX positions based on recent financial reports or guidance from the company.

HOLX Price Chart

HOLX Technical Analysis

HOLX News

Hologic ( HOLX ) Stock Moves -1.25%: What You Should Know

The latest trading day saw Hologic (HOLX) settling at $67.76, representing a -1.25% change from its previous close.

https://www.zacks.com/stock/news/2766644/hologic-holx-stock-moves--125-what-you-should-know

Trending Today

ZCash ($ZEC) Crypto Forecast: Down 5.1% Today

Silver ($XAG) Commodity Forecast: Up 5.3% Today

Hologic Inc. ($HOLX) Stock Forecast: Down 2.9% Today

Plug Power Inc. ($PLUG) Stock Forecast: Up 5.1% Today

Wingstop Inc. ($WING) Stock Forecast: Up 5.0% Today

Astera Labs Inc ($ALAB) Stock Forecast: Down 5.9% Today

ARM Holdings plc ($ARM) Stock Forecast: Up 5.1% Today

S&P Global Inc. ($SPGI) Stock Forecast: Down 1.9% Today

Beyond Meat Inc. ($BYND) Stock Forecast: Up 12.3% Today

Arista Networks Inc. ($ANET) Stock Forecast: Down 6.2% Today

Hologic Inc. Price History

17.09.2024 - HOLX Stock was down 1.9%

• Concerns have arisen among investors due to the $350 million acquisition of Gynesonics and its potential short-term financial impact on Hologic.
• The market's response to this acquisition suggests a perception of heightened competition within the women's health industry, prompting a sell-off of HOLX shares.
• Investor caution regarding the integration of Gynesonics' Sonata System into Hologic's product lineup is fostering uncertainty and contributing to a downward trend in the stock price.

18.08.2025 - HOLX Stock was up 5.5%

• HOLX witnessed a significant upward movement in the market.
• The company's global presence remains robust, with strong growth in surgical products and increased utilization of diagnostics balancing out short-term obstacles.
• The spike in HOLX's stock value may be linked to the rejuvenation of its Breast Health segment, fueled by advancements in AI, changes in leadership, and product enhancements.
• Despite potential challenges ahead, investors appear positive about HOLX's future growth, driving the bullish trend in its stock performance.

10.11.2024 - HOLX Stock was up 2.1%

• An analyst recently initiated coverage on Hologic, Inc. with an optimistic outlook, potentially influencing investor sentiment and interest in the stock.
• Although there has been a slight decrease in the stock price post their last earnings report, investors seem hopeful for a recovery based on favorable analyst coverage and growth prospects in the medical technologies industry.
• The positive movement in HOLX today may be attributed to growing investor confidence, spurred by favorable analyst assessments and expectations of a potential stock price revival following the recent earnings report.

28.04.2025 - HOLX Stock was up 13.7%

• Recently, Hologic experienced a significant uptrend in its stock price, triggered by an undisclosed bid from TPG and Blackstone. The proposal values the company at $70-$72 per share, representing a notable premium compared to its prior close.
• The market's reaction signaled strong approval of the potential acquisition bid, reflecting investor confidence in Hologic's worth and its growth potential within the women's health sector.
• Despite encountering challenges such as tariff implications and reduced demand, Hologic's leading position in women's health diagnostics has placed it in a favorable position for prospective strategic collaborations and acquisitions, leading to an increase in its stock value.

05.10.2024 - HOLX Stock was down 5.6%

• HOLX stock experienced a bearish movement due to Q4 earnings missing estimates by -0.98%.
• The disappointing financial results may have led to a lack of investor confidence and a subsequent sell-off of the stock.
• Investors had higher expectations for Hologic's performance, leading to concerns about future growth prospects.
• A closer examination of key metrics beyond traditional estimates could provide insights into areas of underperformance, prompting investors to reassess the stock's potential.

17.08.2025 - HOLX Stock was up 4.7%

• HOLX showed bullish movement, potentially influenced by:
• Optimism surrounding the revival of the company's Breast Health division, backed by AI advancements, leadership changes, and product enhancements.
• Investor confidence in HOLX's growth potential following these positive changes.
• Recent short-term bearish movement, which could be viewed as a minor fluctuation in the midst of HOLX's overall bullish trajectory driven by advancements in its Breast Health segment.

06.01.2025 - HOLX Stock was down 7.4%

• HOLX performed well in Q1 but issued a bleak sales forecast for 2025, resulting in a pessimistic market outlook.
• The stock price was affected as investors responded unfavorably to the lower sales projection for 2025.
• Despite strong Q1 earnings, the market predominantly reacted to the future sales guidance, causing a decline in the stock value.
• Investors' focus on forward-looking guidance over historical performance was evident in the market's response.

08.03.2025 - HOLX Stock was down 4.2%

• The addition of new leadership at Hologic may have initially been seen as a positive move, indicating potential stability and growth for the company.
• However, the mention of ongoing global uncertainties could have spooked investors, leading to a bearish movement in the stock.
• Investors may be cautious due to the uncertain global economic outlook, causing them to reevaluate their positions in HOLX despite its strong diagnostics strength and international potential.

02.04.2025 - HOLX Stock was down 8.5%

• Despite Hologic (HOLX) delivering a strong earnings and revenue beat in the second quarter of fiscal 2025, the stock experienced a bearish movement.
• The lowering of the EPS view for the future might have dampened investor sentiment, leading to the negative market reaction.
• The market could be reacting to macroeconomic turbulence, which might be impacting the overall sentiment towards the stock.
• Investors might be concerned about the potential impact of the lowered EPS view and the uncertainties in the macroeconomic environment, leading to the bearish movement in HOLX.

13.09.2025 - HOLX Stock was down 2.9%

• HOLX stock decreased by -1.25%, closing at $67.76.
• The bearish movement may stem from profit-taking by investors following a recent uptrend in the stock.
• Investor caution could be linked to competition in the medical diagnostic industry or overall market volatility affecting HOLX.
• Some investors could be reassessing their HOLX positions based on recent financial reports or guidance from the company.

10.06.2025 - HOLX Stock was up 3.0%

• The bullish movement in HOLX stock today can be attributed to the company's strong momentum in its GYN Surgical arm, driven by the success of Fluent Pro, global expansion efforts, and strategic acquisitions.
• Despite concerns raised about HOLX's low valuation and challenges in certain segments like Breast Health sales and risks in China, investors seem to be focusing more on the positive growth drivers in the GYN Surgical division.
• The market seems to be optimistic about Hologic's ability to capitalize on its strengths in women's health and surgical solutions, overlooking some of the short-term challenges highlighted.

27.04.2025 - HOLX Stock was up 6.5%

• The bullish movement in HOLX today could be attributed to the positive comparison with Quest Diagnostics in terms of investor appeal and market performance.
• Investors may be favoring HOLX over DGX due to its strong position in the growing women's health sector, leading to increased buying activity and driving the stock price higher.
• Highlighting HOLX as a better pick compared to DGX might have sparked investor interest and confidence in the company's future prospects, contributing to the bullish market movement.